Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotics vs Corticosteroids in Granulomatous Lobular Mastitis
NCT07454772Phase 2Not yet recruiting
- Sponsor
- AIIMS New Delhi
- Start
- Mar 2026
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of clarithromycin, ofloxacin and rifaximin in Granulomatous lobular mastitis (GLM) (2 arms), sponsored by AIIMS New Delhi. Primary endpoint: Complete Clinical Response at 2 months. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
clarithromycinofloxacinrifaximin
03
Conditions
Granulomatous lobular mastitis (GLM)
Beyond the preview
Go deeper on NCT07454772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07454772.